Wize Pharma

Wize Pharma Cash Flow per Share

Delisted·Jan 10, 2019

The Operating Cash Flow per Share of Wize Pharma (WIZP) as of Oct 18, 2026 is -0.05 USD. In the previous year, Operating Cash Flow per Share was -0.13 USD — a change of -64.37% (higher).

Cash Flow per Share

-0.05USD

YoY

-64.37%

Last updated:

Operating Cash Flow per Share of Wize Pharma is 2020 -0.05 USD. Operating Cash Flow per Share of Wize Pharma was 2019 -0.13 USD. It decreases by -64.37% higher compared to the previous year.

The Wize Pharma Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2014
-0.24 USD
Jan 1, 2015
-4.46 USD
Jan 1, 2016
-1.99 USD
Jan 1, 2017
-0.31 USD
Jan 1, 2018
-0.25 USD
Jan 1, 2019
-0.13 USD
Jan 1, 2020
-0.05 USD
The Wize Pharma Cash Flow per Share history
YEARCash Flow per ShareYoY
-0.05USD-64.37%
-0.13USD-47.25%
-0.25USD-21.38%
-0.31USD-84.22%
-1.99USD-55.48%
-4.46USD+1,769.52%
-0.24USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Wize Pharma Stock analysis

What does Wize Pharma do? Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wize Pharma stock

Operating Cash Flow per Share of Wize Pharma is -0.05 USD in 2020.

Operating Cash Flow per Share of Wize Pharma changed from -0.13 USD to -0.05 USD, representing a -64.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Wize Pharma since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Wize Pharma

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Wize Pharma